povidone-iodine has been researched along with Lymphatic-Diseases* in 3 studies
3 other study(ies) available for povidone-iodine and Lymphatic-Diseases
Article | Year |
---|---|
Instillation of povidone iodine to treat lymphocele and leak of lymph after renal transplantation.
Lymphoceles are common surgical complications of renal transplantation. Recently minimal invasive therapy has been advised. We studied the safety and efficacy of instillation of povidone iodine via transcutaneous catheter for treatment of lymphoceles and leaks of lymph. We studied 10 (four males, six females) kidney transplant recipients who developed lymphoceles after transplantation and four (three males, one female) who developed leaks of lymph. We treated these cases by povidone iodine after placement of transcutaneous catheters with guidance of ultrasound and confirmed the presence of lymph by biochemical analysis. After dilution of povidone iodine to 5% with normal saline, 20cc were instilled and dwelled in the cavity for 30 minute three times daily. The lymph was then allowed to drain by gravity. For the leaks of lymph, which occurred immediately post operation, the catheters were placed during transplantation surgery. All patients were followed up for four months. After one week of instillation, all lymph leaks were completely blocked. Furthermore, nine (90%) cases of lymphocele resolved after 15 days of therapy. We conclude that instillation of diluted povidone iodine for treatment of lymphocele and leak of lymph is safe and effective and it may be considered as first choice for these conditions. Topics: Adolescent; Adult; Anti-Infective Agents, Local; Child; Female; Fistula; Humans; Instillation, Drug; Kidney Transplantation; Lymphatic Diseases; Lymphocele; Male; Middle Aged; Postoperative Complications; Povidone-Iodine; Treatment Outcome | 2007 |
Lymphoceles: percutaneous treatment with povidone-iodine sclerosis.
Although percutaneous procedures have gained a degree of acceptance for treatment of lymphoceles, success rates for aspiration and drainage have been less than optimal. The authors investigated transcatheter sclerosis of pelvic lymphoceles with povidone-iodine as a method to increase the success rate of percutaneous management. Eight patients with a total of nine pelvic lymphoceles were treated with this method. Eight of the nine lymphoceles (89%) resolved without complications. Four patients had undergone lymphadenectomy and four, renal transplantation. The duration of catheter drainage ranged from 15 to 37 days. Four of the lymphoceles were found to be infected at initial drainage, but this did not alter the amount of time the catheter was left in place. One lymphocele failed to heal with sclerotherapy and required internal drainage. The early results with transcatheter povidone-iodine sclerosis of postoperative lymphoceles are encouraging and warrant further evaluation. Topics: Humans; Kidney Transplantation; Lymph Node Excision; Lymphatic Diseases; Lymphocele; Pelvis; Postoperative Complications; Povidone; Povidone-Iodine; Sclerosing Solutions | 1989 |
Povidone-iodine sclerosis of pelvic lymphoceles: a prospective study.
Twelve patients presented for percutaneous catheter drainage of 13 postoperative pelvic lymphoceles. Six patients with 7 lymphoceles were treated with povidone-iodine sclerosis prior to catheter removal. Only 1 lymphocele (which continued to drain large amounts of fluid during and after the sclerosis procedure) recurred. Six patients with 6 lymphoceles had their percutaneous catheters removed without sclerosis. Fluid collections recurred in 3 instances, necessitating repeat percutaneous drainage (2 patients) or surgery (1 patient). Percutaneous therapy is the treatment of choice for patients with postoperative lymphoceles. Povidone-iodine sclerosis is often effective in preventing reaccumulation of fluid once the lymphocele cavity is collapsed. Topics: Adult; Drainage; Female; Humans; Lymphatic Diseases; Lymphocele; Male; Middle Aged; Povidone; Povidone-Iodine; Prospective Studies; Sclerosing Solutions | 1988 |